Supplementary Figure S7 from Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children’s Oncology Group
Year: 2024
Type: supplementary-materials
Abstract: SRC proto-oncogene, non-receptor tyrosine kinase expression in scRNAseq.
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4402221144